Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Non-Current Deferred Tax Liability (2021 - 2024)

Historic Non-Current Deferred Tax Liability for Prime Medicine (PRME) over the last 4 years, with Q1 2024 value amounting to $134000.0.

  • Prime Medicine's Non-Current Deferred Tax Liability rose 7402.6% to $134000.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $134000.0, marking a year-over-year increase of 7402.6%. This contributed to the annual value of $8.7 million for FY2022, which is 4656.5% up from last year.
  • Prime Medicine's Non-Current Deferred Tax Liability amounted to $134000.0 in Q1 2024, which was up 7402.6% from $108000.0 recorded in Q2 2023.
  • In the past 5 years, Prime Medicine's Non-Current Deferred Tax Liability registered a high of $8.7 million during Q4 2022, and its lowest value of $77000.0 during Q1 2023.
  • For the 4-year period, Prime Medicine's Non-Current Deferred Tax Liability averaged around $2.6 million, with its median value being $307500.0 (2022).
  • Per our database at Business Quant, Prime Medicine's Non-Current Deferred Tax Liability soared by 4656.5% in 2022 and then skyrocketed by 7402.6% in 2024.
  • Prime Medicine's Non-Current Deferred Tax Liability (Quarter) stood at $6.0 million in 2021, then soared by 46.57% to $8.7 million in 2022, then crashed by 98.77% to $108000.0 in 2023, then increased by 24.07% to $134000.0 in 2024.
  • Its Non-Current Deferred Tax Liability stands at $134000.0 for Q1 2024, versus $108000.0 for Q2 2023 and $77000.0 for Q1 2023.